BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28502234)

  • 1. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
    Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
    Ozcelik B; Turkyilmaz C; Ozgun MT; Serin IS; Batukan C; Ozdamar S; Ozturk A
    Fertil Steril; 2010 Mar; 93(5):1609-14. PubMed ID: 19339002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.
    Danforth DR; Arbogast LK; Friedman CI
    Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
    Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model.
    Tan SJ; Yeh YC; Shang WJ; Wu GJ; Liu JY; Chen CH
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):182-5. PubMed ID: 20074846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of GnRH analogs on the expression of Bcl-2 gene family in the ovary of rats with cyclophosphamide-induced ovarian damage].
    Peng P; Yang DZ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2014-7. PubMed ID: 19033116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship?
    Yüce MA; Balkanli Kaplan P; Gücer F; Doğanay L; Altaner S; Canda T; Yardim T
    Eur J Gynaecol Oncol; 2004; 25(5):628-31. PubMed ID: 15493183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the prevention of chemotherapy-induced ovarian damage by gonadotropin-releasing hormone agonist in rat model].
    Yuan GW; Shen K; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):666-9. PubMed ID: 16277895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Atakul T; Tayyar AT; Turan ÖD; Çelik SY; Yılmaz M; Küçük M; Yüksel H; Demirci B
    Gynecol Endocrinol; 2021 Jan; 37(1):46-50. PubMed ID: 32283955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of gonadotropin-releasing hormone agonist on the effect of chemotherapy upon ovarian cancer and the prevention of chemotherapy-induced ovarian damage: an experimental study with nu/nu athymic mice.
    Lin QY; Wang YF; Weng HN; Sheng XJ; Jiang QP; Yang ZY
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):894-903. PubMed ID: 23125082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?
    Parlakgumus HA; Kilicdag EB; Bolat FA; Haydardedeoglu B; Parlakgumus A
    Arch Gynecol Obstet; 2015 Jun; 291(6):1403-10. PubMed ID: 25472738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
    Matsuo G; Ushijima K; Shinagawa A; Takahashi S; Fujiyoshi N; Takemoto S; Terada A; Fukui A; Kamura T
    Kurume Med J; 2007; 54(1-2):25-9. PubMed ID: 18332593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
    Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Huang YH; Zhao XJ; Zhang QH; Xin XY
    Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
    Kishk EA; Mohammed Ali MH
    Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.